ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
0 hedge funds and large institutions have $0 invested in ENZON PHARMACEUTICALS INC in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| – | -$1K | -6,653 | Closed |
|
ENZN Hedge Fund Activity: Q2 2020 in Review
0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2020, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENZN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Victory Capital Management, exiting entirely with an estimated $1K sold.
- 0 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2020, down from 1 in Q1 2020.
- Funds reported $0 of ENZON PHARMACEUTICALS INC stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest ENZON PHARMACEUTICALS INC seller in Q2 2020 was Victory Capital Management, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2020.